Advanced formulations for improving therapies with anti-inflammatory or anaesthetic drugs: A review

被引:20
|
作者
Maestrelli, Francesca [1 ]
Bragagni, Marco [1 ]
Mura, Paola [1 ]
机构
[1] Univ Florence, Dept Chem, Via Ugo Schiff 6, I-50019 Florence, Italy
关键词
Micro- and nanotechnologies in pain management; Cyclodextrin complexation; Solid dispersions; Vesicular systems; Micro and nanoparticles; Microemulsions; HYDROXYPROPYL-BETA-CYCLODEXTRIN; SOLID LIPID NANOPARTICLES; IN-VITRO EVALUATION; SUPERCRITICAL CARBON-DIOXIDE; TYPED LOCAL-ANESTHETICS; WATER-SOLUBLE DRUG; PHYSICOCHEMICAL CHARACTERIZATION; DISSOLUTION PROPERTIES; INCLUSION COMPLEXATION; STATE CHARACTERIZATION;
D O I
10.1016/j.jddst.2015.09.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The development of new more effective therapeutic treatments for pain relief is essential for enhancing the patient quality of life and safety and avoiding or limiting risks of abuse, addiction or serious injuries posed by some of the present pain therapies. With this aim, in the last years, several advanced delivery systems have been developed to increase bioavailability, therapeutic efficacy and safety of well known analgesics, overcoming limits and drawbacks of traditional formulations. Among the different kinds of drugs used in the treatment of pain, non-opioid drugs such as local anaesthetics, corticosteroids and non steroidal anti-inflammatory drugs are preferred in the treatment of mild or moderate pain. However, each of these classes is associated with different adverse events and inconveniences, most of which could be reduced or overcome by appropriate drug carrier systems. This review is focused on recent drug delivery strategies based on micro- and nano-technologies developed for improving the effectiveness in pain management through non-opioid agents, exploiting different approaches such as: cyclodextrin complexation, solid dispersions with hydrophilic polymers, mechano-chemically activated systems, micro and nanoparticles, micro and nano-emulsions, vesicular systems. Combined approaches, simultaneously exploiting the relative advantages of such systems in a single drug delivery device, were also reviewed. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:192 / 205
页数:14
相关论文
共 50 条
  • [31] IMMUNOMODULATION BY ANTI-INFLAMMATORY DRUGS
    DREHER, R
    FINK, K
    SEIDEL, H
    WAGNER, P
    ROHRBACH, B
    FEDERLIN, K
    IMMUNITAT UND INFEKTION, 1983, 11 (04): : 123 - 134
  • [32] PROSTAGLANDINS AND ANTI-INFLAMMATORY DRUGS
    ROBINSON, DR
    DM DISEASE-A-MONTH, 1983, 30 (03): : 1 - 46
  • [33] Proapoptotic anti-inflammatory drugs
    Myers, C
    Koki, A
    Pamukcu, R
    Wechter, W
    Padley, RJ
    UROLOGY, 2001, 57 (4A) : 73 - 76
  • [34] Anti-inflammatory drugs and the kidney
    House, A. A.
    Oliveira, S. Silva
    Ronco, C.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2007, 30 (12): : 1042 - 1046
  • [35] ANALGESIC ANTI-INFLAMMATORY DRUGS
    CHAMPION, GD
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1975, 5 (06): : 583 - 584
  • [36] ANTI-INFLAMMATORY DRUGS AS ANTIBIOTICS
    不详
    CHEMICAL & ENGINEERING NEWS, 2014, 92 (11) : 35 - 35
  • [37] ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY
    CREWS, SJ
    PRACTITIONER, 1966, 197 (1177) : 36 - &
  • [38] Nonsteroidal anti-inflammatory drugs
    Tseng, CC
    Wolfe, MM
    MEDICAL CLINICS OF NORTH AMERICA, 2000, 84 (05) : 1329 - +
  • [39] Nonsteroidal anti-inflammatory drugs
    Moses, VS
    Bertone, AL
    VETERINARY CLINICS OF NORTH AMERICA-EQUINE PRACTICE, 2002, 18 (01) : 21 - +
  • [40] Emerging Anti-inflammatory Therapies for Atherosclerosis
    Roubille, Francois
    Kritikou, Ekaterini A.
    Roubille, Camille
    Tardif, Jean-Claude
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (33) : 5840 - 5849